Atlas Trials

Controlled Ovarian Stimulation

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Controlled Ovarian Stimulation

RecordFirmDate
Study to Assess the Design of Use of REKOVELLE® in Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures in Routine Clinical Practice (NCT04503707)Ferring Pharmaceuticals2020-06-17
N680S Polymorphism of the FSHR Gene and Its Relationship With the Type of Gonadotropin Used in COS (NCT04122729)Angelini Farmacéutica2019-09-25
Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE® (NCT03697031)Ferring Pharmaceuticals2018-09-01
A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation. (NCT03564509)Ferring Pharmaceuticals2018-05-14
Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures (NCT03393780)Ferring Pharmaceuticals2018-03-16
Progesterone Variation on the Final Day of Oocyte Maturation. (NCT03366025)Fundacion Dexeus2017-11-01
To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran® (NCT03051087)LG Life Sciences2016-10-01
Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART) (NCT01339299)Regionshospitalet Viborg, Skive2009-10-01
A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703) (NCT00725491)Organon and Co2007-05-01
Japanese Bridging Trial of Org 37462 (Study P05969)(COMPLETED) (NCT00988260)Organon and Co2003-02-03
Endometrial Luteal Phase Characteristics and Luteal Phase Support in Controlled Ovarian Stimulation Protocols With GnRH Antagonists:Focusing on MicroRNA (NCT01510054)Johns Hopkins University2002-07-01

Track Controlled Ovarian Stimulation automatically

Every clearance here is in the API, with alerts when new ones post.